Creo Medical Share News (CREO)

Creo device used in 'groundbreaking' lung cancer procedure

(Sharecast News) - Creo Medical Group announced a significant milestone in the field of minimally-invasive surgical endoscopy for cancer patients on Friday, with its 'MicroBlate Flex' device.

EARNINGS AND TRADING: Dar Global celebrates "outstanding" year

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

Creo Medical FY revenues up double digits

(Sharecast News) - Medical device company Creo Medical said on Wednesday that 2023 was "a pivotal year" for the firm, with new products supporting "strong growth" and leading to a double-digit jump in group revenues.

Creo Medical makes "considerable strides" toward 2025 break-even goal

(Alliance News) - Creo Medical Group PLC on Wednesday said that cost controls and new product sales had supported strong growth in 2023, as the company said it is on track to achieve cash flow break-even by 2025.

IN BRIEF: Creo Medical partners with Khalifa University in Abu Dhabi

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Will collaborate with Khalifa University of Science & Technology in Abu Dhabi. Says partnership has an initial focus on healthcare challenges relevant to the population in the United Arab Emirates, as well as the wider Middle East and North Africa region. Chief Executive Officer Craig Gulliford says: "As part of our strategy, we are driven to exploit our IP either directly or in partnership with third-parties, as shown by our robotic assisted surgery collaborations. Khalifa University is a research-intensive organisation with a similar drive to develop and commercially exploit leading technologies, at scale and on a global basis. The combination of Creo's people, technology and IP with Khalifa University's teams, technologies, facilities and resources represents a great opportunity for both organisations to advance and commercialise incremental technology and products and enhance research profiles internationally."

TRADING UPDATES: Creo unveils product in APAC; Unilever hires director

(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Creo Medical's Speedboat UlstraSlim device used in Latin America

(Alliance News) - Creo Medical Group PLC on Wednesday said its Speedboat UltraSlim device has been used successfully in Latin America for the first time.

IN BRIEF: Creo Medical's SpeedBoat UltraSlim successfully used in US

Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Says SpeedBoat UltraSlim device has been successfully used in the US across multiple clinical applications. SpeedBoat UltraSlim is third brand in its Speedboat family of devices alongside Speedboat Inject and offers a number of different features.This primarily includes the reduced size in comparison with the Speedboat Inject, Creo Medical said, making the device compatible with all endoscopes with a 2.8 millimetre working channel or larger.

TRADING UPDATES: Good Energy says ZapMap expands into mainland Europe

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:

Creo launches 'Speedboat Ultraslim' with first UK procedure

(Sharecast News) - Creo Medical Group announced a significant milestone for its Speedboat UltraSlim medical device in the field of surgical endoscopy on Wednesday.

Creo Medical gets US FDA clearance for Speedboat UltraSlim

(Sharecast News) - Medical device company Creo Medical Group announced on Wednesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device.

Creo Medical accelerating EU launch of Speedboat UltraSlim

(Sharecast News) - Creo Medical Group announced the acceleration of its EU launch of the 'Speedboat UltraSlim' device by around 18 months on Wednesday.

Creo Medical says EU launch of SpeedBoat UltraSlim device accelerated

(Alliance News) - Creo Medical Group PLC on Wednesday said the EU launch of its SpeedBoat UltraSlim device has been accelerated by around 18 months ahead of schedule.

Creo Medical hails Speedboat Inject device as interim loss narrows

(Alliance News) - Creo Medical Group PLC on Tuesday reported a narrowed interim loss amid higher revenue.

UK earnings, trading statements calendar - next 7 days